The page is the record's research on the issuer — no analyst, no rating, no view.

# Cellectar Biosciences, Inc. (NASDAQ: CLRB) — research page

As of 2026-11-08 · us-cm-kg · record version 1

## Identity and listing

The issuer is Cellectar Biosciences, Inc., listed on NASDAQ under the ticker CLRB, with ISIN US15117F8804 and LEI 5493000NFZCRG7BYQV93. Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States — Delaware. The issuer is listed and not halted.

## The disclosure read

The record holds 49 filings in the twelve months to 2026-11-08, across 27 filing days. The median gap between filing days is 3.5 days. The latest filing is dated 2026-08-14 and is of type regulatory_filing, 86 days before the record date. The NASDAQ median cadence gap is 6.0 days, the NASDAQ median filings count is 52, and the NASDAQ median latency is 5.0 days. The 2834 Pharmaceutical Preparations sector median cadence gap is 6.0 days, its median filings count is 63.0, and its median latency is 4.0 days. The filings by type are 3 agm_egm, 1 corporate_news, 2 director_change, 14 directors_dealings, 5 prospectus, 15 regulatory_filing and 9 results.

## Auditor

The auditor of record is Deloitte & Touche LLP, located in Morristown, New Jersey. The record holds no auditor changes.

## Events and halts

The record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.

## Orderability

The outcome is not determinable, because the chapter's orderability section carries no client_categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter was as of 2026-11-04.

## Coverage

No research houses were found on the issuer's own investor-relations page. The count is 0.

## Open research

No openly published research notes were found. The count is 0.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The issuer is held in sealed years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

## Sources

9 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- https://data.sec.gov/submissions/CIK0001279704.json (identity.jurisdiction)
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- https://mcp.us-cm-kg.ai/events/NASDAQ/CLRB (the disclosure lines)
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- https://www.sec.gov/Archives/edgar/data/1279704/000110465926023167/clrb-20251231x10k.htm (the auditor)
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- https://mcp.us-cm-kg.ai/record/NASDAQ/CLRB (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/CLRB · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp